☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
EU Approval
Insights+: EMA Marketing Authorization of New Drugs in April 2024
May 21, 2024
Insights+: EMA Marketing Authorization of New Drugs in March 2024
April 22, 2024
Insights+: EMA Marketing Authorization of New Drugs in February 2024
March 20, 2024
Insights+: EMA Marketing Authorization of New Drugs in January 2024
February 21, 2024
UCB's Vimpat (lacosamide) Receives CHMP's Positive Opinion for Primary Generalized Tonic-Clonic Seizures
October 23, 2020
Novartis Receives EU Approval for Gene Therapy Luxturna (voretigene neparvovec) in Patients with Rare Inherited Retinal Disease
November 26, 2018
Load more...
Back to Home